The naturally occurring monoterpene 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane 1, commonly named 1,8-cineole and the major component in the leaf oil of many eucalypts, exhibits bioactivity, being potentially antimicrobial and pesticidal. A range of derivatives of 1,8-cineole and its naturally occurring isomeric analogue 1,4-cineole 2, 1-isopropyl-4-methyl-7-oxabicyclo[2.2.1]heptane, were synthesised. High-cineole eucalyptus oil, 1,8-cineole and the 1,8- and 1,4-cineole derivatives were shown to have a dose dependent pre-emergence and post-emergence herbicidal activity against radish (Raphanus sativus var. Long Scarlet), and annual ryegrass (Lolium rigidum) in laboratory bioassays. A postulated increase in activity of the ester derivatives due to metabolic cleavage into their bioactive hydroxy-cineole and carboxylic acid portions after uptake by the plant was not observed. The role of mallee eucalypts in the rehabilitation of degraded farmland in the Western Australian wheat belt, uses of eucalyptus oil and the bioactivity of essential oils and naturally occurring terpenes, with particular emphasis on eucalyptus oil and 1,8-cineole, were reviewed. The review encompasses allelopathic and herbicidal activity, insecticidal, acaricidal and antimicrobial activity. 1,8-Cineole compounds functionalised at position 3 of the cyclohexane ring and the 1,4-cineole derivatives were chemically synthesised whilst 2-endo-hydroxy-1,8-cineole was obtained as the primary metabolite of a novel bacterium grown on 1,8-cineole as sole carbon source. The bacteria were isolated by inoculating liquid growth medium containing 1,8-cineole as carbon source with aliquots of deionised water in which eucalyptus leaves had been stirred. Sequencing of its 16S rRNA gene identified the bacteria as belonging to the order Sphingomonadales, family Sphingomonadaceae and genus Sphingomonas. Growth curves for the bacterium are described and a metabolic pathway for the microbial degradation of 1,8-cineole is confirmed. Bacteria were cultured on a 20 L scale to provide sufficient 2-endo-hydroxy-1,8-cineole for the herbicidal bioassays.

Industrial chemicals known as polychlorinated biphenyls (PCBs) were widely used for decades until their production was banned worldwide due to their persistence and toxicities to humans and other animals. Upon oxidative metabolism by cytochrome P450, hydroxylated metabolites of PCBs (OHPCBs) are formed. OHPCBs have been shown to competitively displace thyroxine from transthyretin, block normal hormonal activity, and inhibit phenol or family 1 sulfotransferases (SULTs) which catalyze sulfation of thyroid hormones and estrogens. Recently, three OHPCBs were shown to also interact with hydroxysteroid or family 2 sulfotransferases that play a role in the homeostasis of steroid hormones such as dehydroepiandrosterone (DHEA). The objectives of the studies presented in this thesis were to further examine the effects of selected OHPCBs on the activity of human hydroxysteroid sulfotransferase (hSULT2A1), to develop a three-dimensional quantitative structure activity relationship (3D-QSAR) model for OHPCBs as inhibitors of DHEA-sulfation catalyzed by this enzyme, and to investigate the mechanism of inhibition and binding of OHPCBs to hSULT2A1. All 15 OHPCBs examined inhibited the sulfation of 1 μ M [3H] DHEA, catalyzed by hSULT2A1 with IC50 values ranging from 0.6 to 96 μ M. The OHPCBs with a 3, 5-dichloro-4-hydroxy substitution were the most potent inhibitors of DHEA sulfation, and they were also shown to be substrates for hSULT2A1. Eight OHPCBs were substrates for hSULT2A1, and seven were solely inhibitors (i.e. they inhibited the sulfation of DHEA, yet they were not themselves sulfuryl-acceptors in hSULT2A1-catalyzed reactions). A 3D-QSAR model was developed utilizing comparative molecular field analysis (CoMFA). The model fit the data well and also had good predictability. The kinetics of inhibition showed that these OHPCBs were noncompetitive inhibitors of hSULT2A1. Binding studies utilizing the displacement of a fluorescent probe, 8-anilino-1-naphthalene sulfonic acid, revealed that several of the OHPCBs interact either at more than one binding site or with more than one enzyme conformation. Further exploration of this binding by molecular modeling showed that OHPCBs bind similarly to different conformations of the enzyme. This work has helped in our understanding of the roles of sulfotransferases in the metabolism and toxicities of OHPCBs, and it opens new avenues for future work.

Polychlorinated biphenyls (PCBs) are persistent organic pollutants. Due to their properties, PCBs accumulate in the food-chain and post a threat to the health of human beings and wildlife. Hydroxylated PCBs (OH-PCBs) are oxidative metabolites of PCBs and are more hydrophilic than their parent PCBs. One of the best approaches to break down these contaminants is through bioremediation, which is an environmental friendly process that uses microorganisms to restore natural environment. Towards this goal, we have investigated the toxicity and accumulation of PCBs and OH-PCBs in a Gram-negative bacterium, Escherichia coli. We have also determined the role played by a primary multidrug efflux transporter AcrB on the accumulation of PCBs and OH-PCBs in bacterial cell. We found that one of the PCBs tested was toxic to E. coli, while different OH-PCBs have different levels of toxicity; the acrB knockout strain accumulated significantly more PCBs and OH-PCBs than the wild-type strain, suggesting that these compounds are substrates of the efflux pump; higher cytoplasmic concentrations of OH-PCBs were also observed in the acrB knockout strain using the biosensors. Based on these observations, we conclude that both PCBs and OH-PCBs are substrates of protein AcrB. Therefore the efflux activities of multidrug resistant pumps in Gram-negative bacteria should be considered while designing bioremediation approaches.

Polychlorinated biphenyls (PCBs) and their metabolic derivatives are ubiquitous environmental contaminants. These compounds are of concern because of their persistence and bioaccumulation in nature. PCBs and the hydroxylated metabolites have shown endocrine-disrupting activity. A method of detection in surface water samples is important to identify and quantify the environmental contamination. In this research we have attempted to develop a method of detection. Six representative polychloromethoxybiphenyls (PCMBs) were prepared. The corresponding polychlorobiphenylols, hydroxylated PCB metabolites (OH-PCBs), were prepared from the PCMBs. A method coupling solid phase extraction with liquid chromatography, on-line electrospray ionization, and mass spectrometry (SPE-LC/ESI/MS) was developed for detection of the OH-PCBs in distilled and surface water samples.

Polychlorinated biphenyls (PCBs) are toxic and persistent chemicals that have been largely dispersed into the environment. The biological and abiotic transformations of PCBs often generate hydroxylated derivatives, which have been detected in a variety of environmental samples, including animal tissues and feces, water, and sediments. Because of their toxicity and widespread dispersion in the environment, hydroxylated PCBs (OH-PCBs) are today increasingly considered as a new class of environmental contaminants. Although PCBs are known to be susceptible to microbial degradation under both aerobic and anaerobic conditions, bacterial degradation of OH-PCBs has received little attention. The overall objective of this study is therefore to evaluate the transformation of mono-hydroxylated PCBs by the well characterized aerobic PCB-degrading bacterium, Burkholderia xenovorans LB400. In order to achieve our overall objective, a series of model mono-hydroxylated PCBs have been selected and they are used to determine the toxicity of hydroxylated congeners toward the bacterium B. xenovorans LB400. The biodegradation kinetics and metabolic pathways of the selected OH-PCBs by B. xenovorans LB400 are then characterized using GC/MS. To understand further the molecular basis of the metabolism of OH-PCBs by B. xenovorans LB400, gene expression analyses are conducted using reverse-transcription real-time (quantitative) polymerase chain reaction (RT-qPCR) and microarray technology. More formally, the specific aims of the proposed research are stated as follows: (1) To evaluate the toxicity of selected mono-hydroxylated derivatives of lesser-chlorinated PCBs toward the bacterium B. xenovorans LB400. (2) To assess the degradation of the selected OH-PCBs by B. xenovorans LB400. (3) To gain further understanding of the molecular bases of the metabolism of the selected OH-PCBs by B. xenovorans LB400. Three hydroxylated derivatives of 4-chlorobiphenyl and 2,5-dichlorobiphenyl, including 2'-hydroxy-, 3'-hydroxy-, and 4'-hydroxy- congeners, were significantly transformed by Burkholderia xenovorans LB400 when the bacterium was growing on biphenyl (biphenyl pathway-inducing conditions). On the contrary, only 2'-OH-4-chlorobiphenyl and 2'-OH-2,5-dichlorobiphenyl were transformed by the bacterium growing on succinate (conditions non-inductive of the biphenyl pathway). Gene expression analyses showed that only exposure to 2'-OH-4-chlorobiphenyl and 2'-OH-2,5-dichlorobiphneyl resulted in induction of key genes of the biphenyl pathway, when cells grown on succinate. These observations suggest that 2'OH-PCBs were capable of inducing the genes of biphenyl pathway. These results provide the first evidence that bacteria are able to cometabolize PCB derivatives hydroxylated on the non-chlorinated ring. Genome-wide transcriptional analyses using microarrays showed that 134 genes were differentially expressed in cells exposed to biphenyl, 2,5-dichlorobiphenyl, and 2'-OH-2,5-dichlorobiphneyl as compared to non-exposed cells. A significant proportion of differentially expressed genes were simultaneously expressed or down regulated by exposure to the three target compounds i.e., biphenyl, 2,5-DCB, and 2'-OH-2,5-DCB, which suggests that these structurally similar compounds induce similar transcriptional response of B.xenovorans LB400. Results of this study may have important implications for the natural attenuation of PCBs and fate of OH-PCBs in the environment. The recalcitrance to biodegradation and the high toxicity of some OH-PCBs may provide a partial explanation for the persistence of PCBs in the environment. / Civil Engineering

Polychlorinated biphenyls (PCBs) are widespread persistent organic pollutants. The metabolism of PCBs by various organisms involves many steps that can lead to the formation of a wide range of metabolites. These metabolites frequently exhibit a toxicity and biodegradability different than the parent compounds. There is currently little information available about the biological effects of PCB hydroxylated metabolites that can be generated by various organisms and potentially released into the environment. The objective of the present research is to compare the toxicity of selected PCB congeners and their corresponding mono-hydroxylated metabolites. To achieve this objective, the following specific aims were performed: (1) to determine the effect of selected PCBs and PCB hydroxylated metabolites on the growth rate of a model PCB-degrading bacterium, Burkholderia xenovorans LB 400, (2) to determine the microbial toxicity of PCBs and PCB metabolites using the bioluminescent assay Microtox®, and (3) to determine the estrogenicity of PCBs and PCB metabolites using the Yeast Estrogen Screen assay (YES). The effects of a range of PCBs (PCB-2, -3, -8, -9, -30, -35, -36, -39, -61, -68, and -79) and their mono-hydroxylated metabolites on the growth rate of the PCB degrader, Burkholderia xenovorans LB400, were recorded. The results showed that the parent PCBs (50 mg L-1) did not affect the growth rate of LB400 although their hydroxylated metabolites strongly inhibited microbial growth. Using Microtox® assay, Parent PCBs (50 mg L-1) did not exhibit observable toxicity, while their hydroxylated metabolites showed a high level of toxicity (EC50 ranges from 2 mg L-1 to 46 mg L-1). Results using the YES assay also showed that the estrogenicity of hydroxylated metabolites of PCBs (50 mg L-1) was higher than the parent PCBs. The results obtained from the present study show that mono-hydroxylated metabolites of PCBs are more toxic than the corresponding parent PCBs. Because hydroxylated PCB derivatives are produced by a range of organisms and potentially released into the environment, this work raises new concerns associated with the environmental fate of PCBs. / Civil Engineering

<p>Over time, the Baltic Sea has been contaminated by increasing discharges of pollutants from human activities. Persistent organic pollutants (POPs) have caused toxic effects in wildlife and excess of nutrients have led to eutrophication. Furthermore, there are indications that certain polyhalogenated compounds similar in structure to man-made POPs are produced by the biota present in this sea. In the late 1990’s both methoxylated polybrominated diphenyl ethers (MeO-PBDEs) and hydroxylated-PBDEs (OH-PBDEs) were identified in fish and seals living in this environment. OH-PBDEs can originate from metabolism of PBDEs, but both OH- and MeO-PBDEs are also known to be natural products in marine environments. Another group of POPs, the polybrominated dibenzo-<i>p</i>-dioxins (PBDDs), are not produced commercially, but are known to be by-products of chemical industry and of the combustion of, e.g., brominated flame retardants (BFRs). In contrast to the OH- and MeO-PBDEs, PBDDs have not previously been shown to be natural products, although certain related compounds have been indicated to have a natural origin.</p><p>This thesis describes the identification of PBDDs, OH-PBDEs and MeO-PBDEs in algae, blue mussels and fish living in the Baltic Sea. Several of these compounds were also detected in cyanobacteria. Moreover, PBDDs were present in fish, mussels, shrimp and crabs from different regions of the Baltic Sea and from the west coast of Sweden, but not in organisms from freshwater environments. The levels of these compounds in Baltic fish generally exceeded those of their chlorinated analogues. The origin of the PBDDs identified is somewhat unclear, but the high levels present in blue mussels and the pattern of congeners observed indicate natural production. The presence of PBDDs, OH-PBDEs and MeO-PBDEs in fish and shellfish constitutes a potential risk to both humans and wildlife and requires further investigation.</p>

Over time, the Baltic Sea has been contaminated by increasing discharges of pollutants from human activities. Persistent organic pollutants (POPs) have caused toxic effects in wildlife and excess of nutrients have led to eutrophication. Furthermore, there are indications that certain polyhalogenated compounds similar in structure to man-made POPs are produced by the biota present in this sea. In the late 1990’s both methoxylated polybrominated diphenyl ethers (MeO-PBDEs) and hydroxylated-PBDEs (OH-PBDEs) were identified in fish and seals living in this environment. OH-PBDEs can originate from metabolism of PBDEs, but both OH- and MeO-PBDEs are also known to be natural products in marine environments. Another group of POPs, the polybrominated dibenzo-p-dioxins (PBDDs), are not produced commercially, but are known to be by-products of chemical industry and of the combustion of, e.g., brominated flame retardants (BFRs). In contrast to the OH- and MeO-PBDEs, PBDDs have not previously been shown to be natural products, although certain related compounds have been indicated to have a natural origin. This thesis describes the identification of PBDDs, OH-PBDEs and MeO-PBDEs in algae, blue mussels and fish living in the Baltic Sea. Several of these compounds were also detected in cyanobacteria. Moreover, PBDDs were present in fish, mussels, shrimp and crabs from different regions of the Baltic Sea and from the west coast of Sweden, but not in organisms from freshwater environments. The levels of these compounds in Baltic fish generally exceeded those of their chlorinated analogues. The origin of the PBDDs identified is somewhat unclear, but the high levels present in blue mussels and the pattern of congeners observed indicate natural production. The presence of PBDDs, OH-PBDEs and MeO-PBDEs in fish and shellfish constitutes a potential risk to both humans and wildlife and requires further investigation.

O metabolismo do triptofano (TRP) se dá por três vias metabólicas: a via das quinureninas, a via serotonérgica e a via das triptaminas. A primeira gera quinurenina e uma gama de produtos secundários e contribui para os fenômenos de tolerância e imunoescape de células tumorais. A via serotonérgica leva à produção de neuromediadores e pode gerar melatonina. Há evidências de que compostos desta via podem controlar o crescimento tumoral. A via das triptaminas origina triptamina (TRY) e N-N-dimetiltriptamina (DMT) e representa a rota menos conhecida de degradação do TRP. Assim, investigamos a via das triptaminas em linhagens de melanoma humano SK-Mel-19 e SK-Mel-147. A expressão gênica das enzimas aminoácido aromático descarboxilase (DDC) e indoletilamina-N-metiltransferase (INMT), que convertem o TRP em TRY e DMT, respectivamente, foi determinada por PCR em tempo real. Os metabólitos desta via foram detectados por LC/MS no sobrenadante das culturas celulares. O teste da ferida (scratch test) e o ensaio clonogênico foram usados a fim de triar uma possível atividade antitumoral de TRY e DMT. Apesar de termos observado a expressão das enzimas DDC e INMT apenas na linhagem SK-Mel-147, ambas produziram triptaminas e metabolizaram TRY e DMT. Dependendo da linhagem houve a produção de ácido indolacético, DMT hidroxilado e produtos de abertura do anel indólico. Por fim, TRY e DMT diminuíram a migração e a proliferação das células tumorais. Há ainda muito a se estudar sobre a participação da TRY e DMT na biologia do tumor e as nossas descobertas ampliam o papel do metabolismo do triptofano no processo tumoral. / Tryptophan (TRP) metabolism occurs by three pathways: kynurenine, serotonergic and tryptamines paths. The first generates kynurenine and a range of secondary products and contributes to tolerance and tumor immune escape. Serotonergic pathway leads to the production of neuromediators and can generate melatonin. There are evidences that compounds of this pathway may control tumor growth. Tryptamines pathway originates tryptamine (TRY) and N, N-dimethyltryptamine (DMT) and represents the less-known route of TRP degradation. Thus, we investigated tryptamines pathway on human melanoma cell lines SK-Mel-19 and SK-Mel-147. Gene expression of the enzymes aromatic amino acid decarboxylase (DDC) and indoletilamina-N-methyltransferase (INMT), which convert TRP to TRY and DMT, respectively, was determined by real time PCR. The metabolites of this pathway were detected by LC/MS in cell culture supernatant. The scratch test and clonogenic assay were used to screen a potential antitumor activity for TRY and DMT. Although we have observed the expression of the enzymes DDC and INMT only on SK-MEL-147, both cells produced tryptamines and metabolized TRY and DMT. Depending on the cell line, products were indoleacetic acid (IAA), hydroxylated-DMT (OH-DMT) and indole opening ring products. Finally, TRY and DMT decreased tumor cells migration and proliferation. There is much to be studied about the participation of TRY and DMT in tumor biology, and our findings extend the role of tryptophan metabolism in tumoral process.

Submitted by Cristhiane Guerra (cristhiane.guerra@gmail.com) on 2017-02-03T15:51:13Z No. of bitstreams: 1 arquivototal.pdf: 2439266 bytes, checksum: 852d348e101a0679a14c24845b557b1e (MD5) / Made available in DSpace on 2017-02-03T15:51:13Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 2439266 bytes, checksum: 852d348e101a0679a14c24845b557b1e (MD5) Previous issue date: 2015-07-31 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Phenolic compounds, among them the flavonoids, are holders of antimicrobial, antioxidant and anti-inflammatory effects, but not free from toxicity and/or adverse effects, that's why research in this area, whether they are in silico, in vitro and/or in vivo approach have been intensified to ensure the safe use of these molecules. Thus, the aim of this study was to investigate the probable pharmacological activities, toxicity and antibacterial and antioxidant effects of flavonoid flavone and its hydroxy derivatives: 3-hydroxyflavone, 5-hydroxyflavone and 6-hydroxyflavone, tracing a structure-activity relationship of such substances. It was investigated the pharmacological, pharmacokinetics and theoretical toxicological characteristics of flavonoids using in silico testing with the PASS online and Osiris softwares; the cytotoxicity on human erythrocytes of blood types A, B and O positive and negative Rh factor, running the models of hemolysis and Erythrocyte Osmotic Fragility (EOF); was analysed the antimicrobial activity in front of Gram-positive (B. subtilis CCT 0516, S. aureus ATCC 25619 and S. aureus ATCC 25925) and Gram-negative, including clinical importance (P. aeruginosa ATCC 8027, P. aeruginosa ATCC 23243, E. coli ATCC 2536, E. coli 101, E. coli 103, E. coli 104, E. coli 105 and E. coli 108); assessed the oxidant and antioxidant potential of these molecules in the presence of Reactive Oxygen Species (ROS - H2O2) and phenylhydrazinium (Ph) and, finally, the genotoxicity using the micronucleus test. The results obtained revealed numerous probable pharmacological activities to the flavonoids, as integrity agonists and membrane permeability inhibitors, anaphylatoxin receptor antagonists, inhibitors of kinase and peroxidase, antimutagenic potential and vase-protecting capacity; do not present significant theoretical toxicity risks and have good oral bioavailability. The 4 flavonoids have shown moderate hemolysis at concentrations of 500 and 1000 μg/mL, the example of 3-hydroxyflavone which induced 20.2 % and 53 % of hemolysis, respectively, in blood type A, Rh+; the flavonoids hydroxylated protected cells types A and O from osmotic stress. All flavonoids exhibited moderate antibacterial activity against Gram-positive strains and Gram-negative, being the flavone bactericide in the concentration of 200 μg/mL to the strains of P. aeruginosa ATCC 8027, S. aureus ATCC 25619 and E. coli 104, while other flavonoids have bacteriostatic action. It did not promote oxidation of erythrocyte and behaved as scavengers and antioxidants of H2O2 and phenylhydrazinium and finally the flavone did not show genotoxicity compared to cyclophosphamide, a proven genotoxic agent. It is concluded that the flavone, 3-hydroxyflavone, 5-hydroxyflavone and 6- hydroxyflavone have different pharmacological activities, good bioavailability and low theoreticals toxicity, reduced cytotoxicity, absence of genotoxicity as well as being moderate antibacterial and antioxidant, showing, with this study, the importance of the inclusion of computational chemistry techniques for targeting evaluation protocols of the biological effects of the molecules. / Compostos fenólicos, dentre eles os flavonoides, são detentores de efeitos antimicrobiano, antioxidante e anti-inflamatório, porém não isentos de toxicidade e/ou efeitos adversos, por isso pesquisas nesta área, sejam elas com uma abordagem in silico, in vitro e/ou in vivo têm se intensificado para que se garanta a segurança no uso dessas moléculas. Assim, o presente estudo se propôs a investigar as prováveis atividades farmacológicas, a toxicidade e os efeitos antibacteriano e antioxidante do flavonoide flavona e de seus derivados hidroxilados: 3-hidroxiflavona, 5-hidroxiflavona e 6-hidroxiflavona, traçando uma relação estrutura-atividade das referidas substâncias. Para tanto, investigou-se as características farmacológica, farmacocinética e toxicológica teóricas dos flavonoides utilizando ensaios in silico com os softwares PASS online e Osíris; a citotoxicidade sobre eritrócitos humanos dos tipos sanguíneos A, B e O e fator Rh positivo e negativo, executando-se os modelos de hemólise e Fragilidade Osmótica Eritrocitária (FOE); analisou-se a atividade antimicrobiana frente a bactérias Gram-positivas (B. subtilis CCT 0516, S. aureus ATCC 25619 e S. aureus ATCC 25925) Gram-negativas, inclusive de importância clínica (P. aeruginosa ATCC 8027, P. aeruginosa ATCC 23243, E. coli ATCC 2536, E. coli 101, E. coli 103, E. coli 104, E. coli 105 e E. coli 108); avaliou-se o potencial oxidante e antioxidante das referidas moléculas na presença de Espécies Reativas de Oxigênio (EROs - H2O2) e da fenilhidrazina (Ph) e, por último, a genotoxicidade por meio do teste do micronúcleo. Os resultados obtidos revelaram numerosas prováveis atividades farmacológicas para os flavonoides, como agonistas da integridade e inibidores da permeabilidade membranar, antagonistas do receptor de anafilatoxina, inibidores de quinase e peroxidase, potencial antimutagênico e capacidade vasoprotetora; não apresentam significativos riscos teóricos de toxicidade e detêm uma boa biodisponibilidade oral. Os 4 flavonoides demonstraram moderada hemólise nas concentrações de 500 e 1000 μg/mL, a exemplo da 3-hidroxiflavona que induziu 20,2 e 53 % de hemólise, respectivamente, no sangue tipo B,Rh-; os flavonoides hidroxilados protegeram os eritrócitos tipos A e O do estresse osmótico. Todos os flavonoides exibiram moderada atividade antibacteriana contra cepas Gram-positivas e Gram-negativas, sendo a flavona bactericida na concentração de 200 μg/mL para as linhagens de P. aeruginosa ATCC 8027, S. aureus ATCC 25619 e E. coli 104, enquanto que os demais flavonoides têm ação bacteriostática. As substâncias não promoveram oxidação dos eritrócitos e comportaram-se como sequestradores e antioxidantes de H2O2 e fenilhidrazina e, por fim, a flavona não apresentou genotoxicidade quando comparado com a ciclofosfamida, um comprovado agente genotóxico. Conclui-se que flavona, 3-hidroxiflavona, 5-hidroxiflavona e 6-hidroxiflavona possuem variadas atividades farmacológicas, boa biodisponibilidade e baixa toxicidade teóricas, reduzida citotoxicidade, ausência de genotoxicidade, além de serem moderadamente antibacterianos e antioxidantes, evidenciando-se, com este estudo, a importância da inserção de técnicas de química computacional para o direcionamento de protocolos de avaliação de efeitos biológicos de moléculas.